RA Capital Management’s Sutro Biopharma STRO Stock Holding History

RA Capital Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.8M	Buy	+715,307	New	+$12.9M	0.19%	61
2025 Q2	–	Sell	-443,464	Closed	-$2.89M	–	83
2025 Q1	$2.89M	Buy	+443,464	New	+$6.98M	0.05%	82
2021 Q2	–	Sell	-211,821	Closed	-$48.2M	–	99
2021 Q1	$48.2M	Hold	211,821	–	–	0.73%	40
2020 Q4	$46M	Hold	211,821	–	–	0.64%	41
2020 Q3	$21.3M	Buy	211,821 +19,857	+10%	+$1.88M	0.39%	47
2020 Q2	$14.9M	Buy	+191,964	New	+$18.4M	0.29%	46

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return